Last week, The New York Times ran a story in its Science section on the impressive development of new therapies that have given those living with MS hope and a better quality of life. Today, thanks to research, there are eight FDA-approved disease-modifying drugs that reduce relapses and slow the progression of MS, as well as treatments approved to manage symptoms related to MS. The Society’s Chief Research Officer Dr. Timothy Coetzee is quoted in the article stating that “We have a disease that’s gone from having no treatments 20 years ago to having multiple treatment options. There is a growing recognition that M.S. is becoming a manageable disease.” This article is a testament to the progress that has been made, as well as a reminder of work remaining that will move us closer to a world free of MS. Click here to read the full story and hear from people with MS who have benefitted from MS therapies, as well as other MS experts, most of whom are affiliated with the Society.
Additionally, ABC News highlights treatment advances for MS. Click here to check it out.
No comments:
Post a Comment